Peter Fasse is a Principal in the Boston office of Fish & Richardson. His practice emphasizes patent prosecution and client counseling in a wide variety of technologies, with an emphasis on biotechnology and other biological and medical fields as well as various "green" technologies. Peter works with clients to develop competitive worldwide patent strategies and to establish solid and defensible patent portfolios. He performs competitive patent analyses and identifies third party patent risks, and provides patentability and freedom-to-operate opinions. Peter has participated in opposing and defending patents in the European Patent Office and in U.S. litigation.
Mr. Fasse has experience in various fields including molecular biology, chemistry, microfluidic systems, medical imaging, optics, biomechanical and biomedical engineering, and various green technologies relating to microbial production of biofuels and electricity as well as wind and solar power. Specific applications relate to, e.g., human and bacterial genes and polypeptides, dental implants, tranexamic acid compositions, microfluidic analysis of fetal blood cells and circulating tumor cells, automated blood analysis systems, nucleic acid probes, tissue engineering, infusion pumps, near infrared scanning catheters, microbes that produce ethanol, laser scanning optical cytometers, lithotriptors, "biochips," laser ablation devices, peptide and DNA vaccines, microbial fuel cells, cellulose processing for ethanol production, CO2 recycling power plants, implantable continuous drug delivery devices and microcapsules, ultrasound probes, cytokines such as IL-8 and PF4, and diagnostic and therapeutic methods for, e.g., AIDS, cancer, autism, diabetes, psoriasis, and arthritis.
In litigation and European opposition matters, Mr. Fasse has represented clients in a variety of patent infringement suits and trade secret misappropriation cases. Specific subject matter at issue included, e.g., cancer therapeutics (Erbitux), methods of treating arthritis (CTL4Ig), dental implants, hook and loop fastener systems, computer-controlled medical infusion pumps, shaving compositions, fiberglass casting material, and bacterial culture media.
Patent Examiner, U.S. Patent and Trademark Office
1984
-
1984
Selected Publications
"Current Views on Obviousness Under US Patent Law," Industrial Biotechnology, Autumn J.S. Hwang and J. Peter Fasse (October 2010).
"'Best Mode' Requirements Under US Patent Law: When Your Best Description is Just Not Good Enough," Industrial Biotechnology, Philip B. Nickson and J. Peter Fasse (August 2010).
"Maximizing IP value in an economic downturn (& beyond) in the life science industry," with Jaclyn M. Mason, Sean M. Dean, and Gwilym J. O. Attwell, Industrial Biotechnology (March 2009).
"Do's and Don'ts for Maximizing Your IP Value in Uncertain Times," J. Peter Fasse (December 2008).
"BENCH TO BENCH: USPTO’s security & energy reviews, Pitfalls and practice tips to help prevent loss of patent rights," with Rolf G. Hille, Industrial Biotechnology (June 2008).
"For better or for worse? How US legislative patent reform may affect the biotech sector," with Elizabeth N. Kaytor and Michael M. Rosen, Industrial Biotechnology (March 2008).
"Issues in Identifying Contributors to Inventions Under U.S. Law," with E. Kaiser, AUTM Technology Transfer Practice Manual, Volume 3, Part 2, Chapter 5 (January 2008).
"Beyond KSR v. Telefex: How the courts and USPTO have decided biotechnology and chemistry cases", with Richard G.A. Bone, M. Angela Parsons, and Gretchen L. Temeles, Industrial Biotechnology (October 2007).
"What the US Supreme Court’s KSR v. Teleflex decision means for biotech," J. Peter Fasse, Industrial Biotechnology (June 2007).
"Intellectual Property (IP) Do's and Don'ts for Start-Up Companies," J. Peter Fasse (March 2007).
"Do's and Don'ts for Keeping Lab Notebooks," J. Peter Fasse.
Selected Presentations
"Biotech and Pharmaceutical Patents at the Federal Circuit: 2010 Year in Review" - A seminar on biotech and pharmaceutical IP law topics (January 18, 2011).
View presentation materials.
"2010 Patent Law Update" - Seminar for University of Massachusetts Technology Transfer Office (April 13, 2010).
"Innovations in Patent Law in Europe and the U.S.: What European Companies Need to Know to Protect Their Most Important Assets," Munich, Germany (February 19, 2009).
"Innovations in Patent Law in Europe and the U.S.: What European Companies Need to Know to Protect Their Most Important Assets," Munich, Germany (January 29, 2008).
"Beyond KSR: What is Obvious Today?," Massachusetts Association of Technology Transfer Offices seminar (January 22, 2008).
"Current Trends in Investing in the Very Small," panel moderator for 3rd Annual Nanotech and Microtech Investors Forum (December 3, 2007).
"Do's and Don'ts for Biotech Startups," panel moderator for BIO 2007 (May 6, 2007).
"Going Green: Ins and Outs of Growing a Green Start Up," panelist at 2007 World Congress on Industrial Biotechnology and Bioprocessing (March 22, 2007).
"Innovations in Patent Law in Europe and the U.S.: What European Companies Need to Know to Protect Their Most Important Assets," Munich, Germany (January 5, 2007).
"The Application of Tiny Technologies to Real Products - An Industry Perspective," panel moderator for 2nd Annual Nanotech Investors Forum (December 4, 2006).
"Innovations in Patent Law in Europe and the U.S.: What European Companies Need to Know to Protect Their Most Important Assets," Munich, Germany (December 1, 2005).
"What You Need To Know About Nanotechnology" Advanced Legal Studies Course at Suffolk University Law School, Boston, MA (October 1, 2004).